Saralyn Mark, MD, highlights the importance of accounting for sex-based biological differences and gender-related factors in understanding disease, interpreting clinical evidence and tailoring treatment. Her session explores lessons learnt from space and how these can be translated back on earth and why a more inclusive, evidence-based approach is essential to advancing personalised healthcare and improving outcomes for every patient.

Across vaccines, oncology, neurodegeneration, and neurosurgery, several companies positioned themselves as next-gen platform builders that could change medicine and healthcare.